HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: dc07-0711v1 31/1/121    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fernandez, M. Articles by Cersosimo, E. Search for Related Content PubMed PubMed Citation Articles by Fernandez, M. Articles by Cersosimo, E. Social Bookmarking                What's this?

Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms

Eugenio.Cersosimo{at}uhs-sa.com

ABSTRACT

Objective: We examined the relationship between glycemic control, vascular reactivity and inflammation in T2DM subjects

Study Design: Thirty subjects with T2DM were initiated on intensive insulin therapy (continuous subcutaneous insulin infusion [n=12] or multiple daily injections [n=18]) and then randomized to either pioglitazone (PIO, 45 mg/d), ramipril (RAM, 10 mg/d), or placebo (PLC) for 36 wks. Euglycemic hyperinsulinemic clamp was used to quatitfy insulin resistance and plethysmography to assess changes in forearm blood flow (FBF) after: (i) 5 min of reactive hyperemia (RH); (ii) brachial artery infusion of acetylcholine (Ach: 7.5,15,30 µg/min) and sodium nitroprusside (SNP: 3,10 µg/min)

Results: The decrease in HbA_1c (9.0 to 7.0%) and FPG (190 to 128 mg/dl) were equal in all groups. In PIO, glucose disposal increased from 3.1 to 4.7 mg/kg•min, and there was a greater decrease in plasma triglycerides (148 vs. 123 mg/dl) and FFA (838 vs. 595 mEq/L) vs. RAM or PLC (p<0.05). Plasma adiponectin doubled with PIO (6.2±0.7 to 13.1±1.8 µg/ml), while endothelin-1 decreased only with RAM (2.5±0.2 to 1.1±0.2 pg/ml, p<001). The increase in FBF during RH (215%) and Ach (from 132 to 205%, 216 to 262%, and 222 to 323%) was greater in PIO vs. RAM or PLC. In contrast, FBF during SNP was greater in RAM (141 to 221% and 218 to 336%) vs. PIO or PLC (all p<0.05).

Conclusion: Addition of PIO or RAM to intensive insulin therapy in T2DM further improves vascular dysfunction. PIO enhances endothelial-mediated, whereas ACE inhibition enhances endothelial-independent vasodilation. These different vascular effects, combined with the observation that PIO decreases FFA and triglycerides and increases adiponectin, while RAM reduces endothelin-1, suggest that different mechanisms underlie the vascular responses.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Saraheimo, C. Forsblom, L. Thorn, J. Waden, M. Rosengard-Barlund, O. Heikkila, K. Hietala, D. Gordin, J. Frystyk, A. Flyvbjerg, et al. Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes Diabetes Care, June 1, 2008; 31(6): 1165 - 1169. [Abstract] [Full Text] [PDF]